Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro

Citation
D. Granato et al., Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro, J PARENT EN, 24(2), 2000, pp. 113-118
Citations number
39
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
ISSN journal
01486071 → ACNP
Volume
24
Issue
2
Year of publication
2000
Pages
113 - 118
Database
ISI
SICI code
0148-6071(200003/04)24:2<113:EOPLEW>2.0.ZU;2-3
Abstract
Background: Numerous studies suggest that immune function may be compromise d by lipid emulsions rich in polyunsaturated fatty acids (PUFAs). In our st udy, we compared the effect of a new olive oil-based lipid Emulsion (ClinOl eic) containing a moderate level of PUFAs, with emulsions based on soybean oil (Intralipid or Ivelip), on immune functions of human cell in vitro. Met hods: peripheral white blood cells were collected from healthy volunteers. Lymphocyte proliferation was evaluated by [H-3]-thymidine incorporation aft er stimulation with either phytohemagglutinin (PHA) or antibodies against T -cell specific antigens. Lymphocytes subsets and T-cell activation markers (CD25 and HLA-DR) were measured by flow cytometry. The release of cytokines (interleukin [IL]-2, IL-1 beta, and tumor necrosis factor-alpha [TNF-cl]) was measured by enzyme-linked immunosorbent. assay (ELISA), after lymphocyt es or monocytes/macrophages stimulation with PHA or lipopolysaccharide (LPS ). Results: A significant dose-dependent inhibition of thymidine incorporat ion was observed with Intralipid and Ivelip (incorporation down to 39.9% of control, p <.001) whereas ClinOleic showed no inhibitory effect. Activatio n antigen expression on both CD4(+) and CD8(+) T-cells tended to decrease w ith Intralipid (CD25: -53.4% on CD4(+) and -57.4% on CD8(+); HLA-DR: -61.5% on CD4(+) and -58.5% on CD8(+)) but not with ClinOleic (from -2.9% for CD2 5 on CD4(+) to 16.7% for HLA-DR on CD4(+)). Intralipid decreased significan tly IL-2 production (-39.0%, p <.05) whereas ClinOleic had little effect (- 13.0%, NS). Intralipid and ClinOleic tended to inhibit to a similar extent the release of pro-inflammatory cytokines (TNF-alpha: -21.5% and -34.8%, IL -1 beta: -45.1% and -40.3%; respectively). Conclusions: Our results suggest that an olive oil-based lipid emulsion could modulate immune response sele ctively, maintaining protective immunity and reducing inflammatory response . Olive oil may offer an immunologically neutral alternative to soybean oil for use in parenteral lipid emulsions.